These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3469468)
1. Synergism or antagonism between estradiol and progesterone on the cell kinetic parameters of the MXT mouse mammary tumor. Kiss R; Danguy AJ; Heuson JC; Paridaens RJ J Natl Cancer Inst; 1987 Mar; 78(3):573-9. PubMed ID: 3469468 [TBL] [Abstract][Full Text] [Related]
2. Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm. Kiss R; de Launoit Y; L'Hermite-Balériaux M; L'Hermite M; Paridaens RJ; Danguy AJ; Pasteels JL J Natl Cancer Inst; 1987 May; 78(5):993-8. PubMed ID: 3472006 [TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of uterine epithelial cell proliferation. I. Effects of estradiol or progesterone administered separately. Kiss R; Lenglet G; Pasteels JL; Danguy A In Vivo; 1987; 1(5):281-9. PubMed ID: 2979795 [TBL] [Abstract][Full Text] [Related]
4. Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm. Kiss R; Paridaens RJ; Heuson JC; Danguy AJ J Natl Cancer Inst; 1986 Jul; 77(1):173-8. PubMed ID: 3459912 [TBL] [Abstract][Full Text] [Related]
5. Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor. Paridaens RJ; Danguy AJ; Leclercq G; Kiss R; Heuson JC J Natl Cancer Inst; 1985 Jun; 74(6):1239-46. PubMed ID: 3858596 [TBL] [Abstract][Full Text] [Related]
6. Effect of estradiol -17- beta (E2) on cell proliferation in the uterus and the MXT mammary tumor borne by intact, ovariectomized and/or hypophysectomized mice. de Launoit Y; Kiss R; Paridaens R; Danguy A; Pasteels JL In Vivo; 1987; 1(3):173-9. PubMed ID: 2979783 [TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of uterine epithelial cell proliferation. II. Effects of estradiol and progesterone administered in combination. Kiss R; Lenglet G; Pasteels JL; Danguy A In Vivo; 1987; 1(5):291-6. PubMed ID: 2979796 [TBL] [Abstract][Full Text] [Related]
8. Effect of estradiol on proliferation and on cell loss in the MXT mouse mammary tumor. Kiss R; Danguy A; Heuson JC; Paridaens R Anticancer Res; 1986; 6(6):1321-8. PubMed ID: 3813488 [TBL] [Abstract][Full Text] [Related]
9. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors. Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654 [TBL] [Abstract][Full Text] [Related]
10. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study. Scheiber C; Kiss R; De Launoit Y; Frühling J Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of the hormone dependent MXT-mouse mammary carcinoma to estradiol during tumoral growth. An autoradiographic study. Kiss R; Paridaens R; Leclercq G; Danguy A Eur J Cancer Clin Oncol; 1986 Jul; 22(7):849-56. PubMed ID: 3770041 [TBL] [Abstract][Full Text] [Related]
12. Proliferative responses of mouse mammary glands to 17 beta-estradiol and progesterone and modification by mouse mammary tumor virus. Lee AE J Natl Cancer Inst; 1983 Dec; 71(6):1265-9. PubMed ID: 6317935 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland. Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489 [TBL] [Abstract][Full Text] [Related]
14. Effect of ovariectomy, hypophysectomy and/or GnRH analog (HRF) administration on the cell proliferation of the MXT mouse hormone-dependent mammary tumor. de Launoit Y; Kiss R; Danguy A; Paridaens R Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1443-50. PubMed ID: 3315693 [TBL] [Abstract][Full Text] [Related]
15. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162 [TBL] [Abstract][Full Text] [Related]
16. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Janik P; Briand P; Hartmann NR Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428 [TBL] [Abstract][Full Text] [Related]
17. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency. Swanson SM; Christov K Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682 [TBL] [Abstract][Full Text] [Related]
18. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976 [TBL] [Abstract][Full Text] [Related]
19. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse. Markaverich BM; Medina D; Clark JH Cancer Res; 1983 Jul; 43(7):3208-11. PubMed ID: 6850631 [TBL] [Abstract][Full Text] [Related]
20. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents. Matsuzawa A; Ikeda Y Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]